Search hospitals > California > Beverly Hills
Retina-Vitreous Associates Medical Group
Claim this profileBeverly Hills, California 90211
Global Leader in Age-Related Macular Degeneration
Global Leader in Macular Edema
Conducts research for Swelling
Conducts research for Diabetic Macular Edema
Conducts research for Atrophy
116 reported clinical trials
2 medical researchers
Summary
Retina-Vitreous Associates Medical Group is a medical facility located in Beverly Hills, California. This center is recognized for care of Age-Related Macular Degeneration, Macular Edema, Swelling, Diabetic Macular Edema, Atrophy and other specialties. Retina-Vitreous Associates Medical Group is involved with conducting 116 clinical trials across 49 conditions. There are 2 research doctors associated with this hospital, such as David Liao, MD, PhD and Beverly Hills Site PI.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
Stage II
CFI rare variant positive
2Macular Edema
Global LeaderVEGF
Top PIs
David Liao, MD, PhDRetina Vitreous Associates Medical Group3 years of reported clinical research
Studies Retinal Disease
Studies Diabetic Retinopathy
2 reported clinical trials
2 drugs studied
Beverly Hills Site PIBeverly Hills Location3 years of reported clinical research
Studies Choroidal Detachment
Studies Retinal Disease
1 reported clinical trial
1 drug studied
Clinical Trials running at Retina-Vitreous Associates Medical Group
Age-Related Macular Degeneration
Macular Edema
Diabetic Retinopathy
Convergence Insufficiency
Swelling
Retinitis
Retinitis Pigmentosa
Retinal Disease
Diabetic Macular Edema
Uveitis
PDS Implant with Ranibizumab
for Age-Related Macular Degeneration
This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular degeneration (nAMD) who have either completed Phase II Study GX28228 (Ladder), Phase III Study GR40548 (Archway), Phase IIIb Study WR42221 (Velodrome), or completed Week 24 visit in Study WR42221 but were not eligible to be randomized in WR42221.
Recruiting2 awards Phase 33 criteria
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
OpRegen
for Age-Related Macular Degeneration
This trial is testing OpRegen, a cell injection treatment, in patients with severe vision loss due to age-related macular degeneration. The goal is to see if injecting these cells under the retina can help repair or support damaged eye cells.
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Retina-Vitreous Associates Medical Group?
Retina-Vitreous Associates Medical Group is a medical facility located in Beverly Hills, California. This center is recognized for care of Age-Related Macular Degeneration, Macular Edema, Swelling, Diabetic Macular Edema, Atrophy and other specialties. Retina-Vitreous Associates Medical Group is involved with conducting 116 clinical trials across 49 conditions. There are 2 research doctors associated with this hospital, such as David Liao, MD, PhD and Beverly Hills Site PI.